Smithkline Beecham obtains United States patent.
Smithkline Beecham Corporation (Philadelphia, PA) has patented TR7 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques. Also disclosed are methods for utilizing TR7 polypeptides and polynucleotides in the design of protocols for the treatment of chronic and acute inflammation acute inflammation
Inflammation having a rapid onset and coming to a crisis relatively quickly, with a clear and distinct termination. , arthritis, septicemia septicemia (sĕptĭsē`mēə), invasion of the bloodstream by virulent bacteria that multiply and discharge their toxic products. The disorder, which is serious and sometimes fatal, is commonly known as blood poisoning. , autoimmune diseases (such as inflammatory bowel disease inflammatory bowel disease
n. Abbr. IBD
Any of several incurable and debilitating diseases of the gastrointestinal tract characterized by inflammation and obstruction of parts of the intestine. and psoriasis), transplant rejection, graft versus host disease Graft versus host disease
A life-threatening complication of bone marrow transplants in which the donated marrow causes an immune reaction against the recipient's body.
Mentioned in: Bone Marrow Transplantation , infection, stroke, ischemia, acute respiratory disease syndrome, restenosis, brain injury, AIDS, bone diseases, cancer (such as lymphoproliferative disorders), atherosclerosis, and Alzheimers disease, among others and diagnostic assays for such conditions. (US 6013476)